Cervical intraepithelial neoplasia and its relationship with hormonal contraceptive methods

Bangladesh Medical Research Council Bulletin

Volumn 34, Issue 1, 2008, Pages 33-34

  Ashrafunnessa, ^a   Kamal, Mohammad ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CHILDBIRTH; COLPOSCOPY; CONTRACEPTION; CONTROLLED STUDY; DELIVERY; EDUCATION; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MARRIAGE; SALPINGECTOMY; SEXUALITY; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 48049113916     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v34i1.1169     Document Type: Article

References (11)

1. Akhter PS, Uddin MM, Sharma SK. Patterns of malignant neoplasm: A three years study. Bangladesh Med J. 1998; 27: 29-32.
2. Kulkarni PV, Jaiswal SS, Rathod SB, Khalique A, Kulkarni RR. Profile of malignancies at medical college, Ambajogai: 15 years retrospective study. Indian J Cancer 1996; 33: 31-36.
3. Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12-19.
4. Brinton LA, Huggins GR, Lehman HF, Mallin K, Savitz DA, Trapido E, Rosenthal J, Hoover R. Long-term use of oral contraceptive and risk of invasive cervical cancer. Int J Cancer 1986; 38: 339-44.
5. Ye Z, Thomas DB, Ray RM. Combined oral contraceptives and risk of cervical carcinoma in situ. WHO collaborative study of neoplasia and steroid contraceptives. Int J Epidemiol. 1995; 24: 19-26.
6. Ylitalo N, Sorensen P, Josefsson A, Frisch M, Sparen P, Ponten J, Gyllensten U, Melbye M, Adami HO. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999; 81: 357-65.
7. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, Angstrom T, Dillner J. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000; 82: 1332-38.
8. Munoz N, Bosch FX, Sanjose SD, Tafur L, Izarzugaza I, Gili M, Viladiu P, Nvarro C, Martoz C, Ascunce N, Gonzalez LC, Kaldor JM, Guerrero E, Lorincz A, Santamaria M Ruiz PA DE, Aristizabal N, Shah K. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 743-49.
9. Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer - further findings from the Oxford Family Planning Association contraceptive study. Br J Cancer 1996; 73: 1291-97.
10. Salazar EL, Contreras H, Gonzalez JL. Effect of oral contraceptive administration on the frequency of estrogen receptor and cervical intraepithelial neoplasia. Gynecol Obstet Mex. 2000; 68: 160-64.
11. Syrjänen K, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Santopietro R, Cintorino M, Tosi P, Syrjanen S. Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections. Anticancer Res. 2006; 26: 4729-40.